Analytical Sciences
Online ISSN : 1348-2246
Print ISSN : 0910-6340
ISSN-L : 0910-6340
Original Papers
Determination of Nalbuphine Hydrochloride in Pharmaceutical Formulations Using Diperiodatoargentate(III)-Rhodamine-B Chemiluminescence System by Flow Injection Analysis
Ahmed KHANMuhammad ASGHARMohammed YAQOOB
Author information
JOURNAL FREE ACCESS

2020 Volume 36 Issue 10 Pages 1223-1230

Details
Abstract

A novel method for the analysis of nalbuphine hydrochloride (NAL) is reported based on its enhancement effect on a diperiodatoargentate(III)-rhodamine-B (Ag(III) complex-Rh-B) chemiluminescence (CL) system in an aqueous sulfuric acid medium using flow-injection analysis (FIA). The optimal conditions of the CL reaction were: sulfuric acid, 10−2 M; Ag(III) complex, 2.0 × 10−4 M; Rh-B, 2.0 × 10−5 M; Brij-35, 0.01%; sample loop volume, 300 μL; and flow rate, 3.0 mL/min/stream. The limit of detection (LOD) and limit of quantification (LOQ) were 0.001 and 0.003 mg/L (S/N = 3 and 10); linear calibration range, 5 × 10−3 – 5.0 mg/L (R2 = 0.9999) and injection throughput, 150/h. The relative standard deviation (RSD) was from 0.8 – 3.2% over the range studied. The suggested technique was applied for the determination of NAL in pharmaceutical injections, compared with a reported spectrophotometric method, and obtained results were found to be satisfactory. Based on spectrophotometric studies, the most probable mechanism of the CL reaction has been briefly described and drawn schematically.

Fullsize Image
Content from these authors
© 2020 by The Japan Society for Analytical Chemistry
Previous article Next article
feedback
Top